4.5 Article

Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Association of Glypican-4 With Body Fat Distribution, Insulin Resistance, and Nonalcoholic Fatty Liver Disease

H. J. Yoo et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Endocrinology & Metabolism

Circulating Sfrp5 Is a Signature of Obesity-Related Metabolic Disorders and Is Regulated by Glucose and Liraglutide in Humans

Wenjing Hu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Review Endocrinology & Metabolism

Metabolic syndrome: its history, mechanisms, and limitations

Eiji Oda

ACTA DIABETOLOGICA (2012)

Article Endocrinology & Metabolism

Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance

Nandita S. Raikwar et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2010)

Article Medicine, General & Internal

Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects

Gangyi Yang et al.

ANNALS OF MEDICINE (2009)

Article Biochemistry & Molecular Biology

Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface

Alexandra Traister et al.

BIOCHEMICAL JOURNAL (2008)

Review Biotechnology & Applied Microbiology

Glypicans

Jorge Filmus et al.

GENOME BIOLOGY (2008)

Article Multidisciplinary Sciences

Evidence for a role of developmental genes in the origin of obesity and body fat distribution

S Gesta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Endocrinology & Metabolism

Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet β cells

RF Bowen et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2001)